Overview
Teresa Law, MD, a breast medical oncologist at Endeavor Health, provides comprehensive, evidence-based care for individuals navigating a breast cancer diagnosis. She combines clinical expertise with emotional support to treat the whole person—addressing physical, emotional and medical needs. Influenced by both her early oncology experience and her mother’s cancer diagnosis, Dr. Law is committed to ensuring patients feel informed, supported and well cared for throughout their journey.
Dr. Law is rated as an Advanced provider by MediFind in the treatment of DICER1 Syndrome. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.
Her clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
757 Park Ave. West, Kellogg Cancer Center, Highland Park, IL 60035
2650 Ridge Ave., Kellogg Cancer Center, Evanston, IL 60201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Endeavor Health Medical Group
Allison DePersia, MD, a medical oncologist at Endeavor Health, specializes in inherited cancer syndromes with a focus on cancer risk assessment, screening and prevention. She supports individuals with increased cancer risk by reviewing family history, genetic testing and other key factors to build personalized screening plans. Dr. DePersia integrates evolving research and innovative screening methods, including emerging blood-based technologies, to help identify cancer earlier when it is more treatable. Her clinical approach emphasizes proactive care grounded in evidence-based practice. Dr. Depersia is rated as an Advanced provider by MediFind in the treatment of DICER1 Syndrome. Her top areas of expertise are BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, DICER1 Syndrome, and Breast Cancer.
Endeavor Health Medical Group
Douglas Edward Merkel, MD, a specialist in oncology at Endeavor Health, provides comprehensive cancer care with a clinical focus on breast cancer. He supports patients across diagnosis and treatment, helping guide their care throughout every stage of their journey. Dr. Merkel is rated as a Distinguished provider by MediFind in the treatment of DICER1 Syndrome. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.
Endeavor Health Medical Group
Mary Jenkins Vogel, MD, a gynecologic oncologist at Endeavor Health, provides advanced cancer care for women using innovative treatments tailored to each patient’s condition. She specializes in personalized medicine, using molecular profiling and the latest research to improve outcomes in endometrial and ovarian cancer. Dr. Jenkins Vogel values collaboration, ensuring patients are supported and involved in every step of their care journey. Dr. Vogel is rated as a Distinguished provider by MediFind in the treatment of DICER1 Syndrome. Her top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, and Bladder Reconstruction.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Law isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Law isDistinguished. Learn about Breast Cancer.
- Breast Cancer in MenDr. Law isDistinguished. Learn about Breast Cancer in Men.
- Inflammatory Breast CancerDr. Law isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Law isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- BRCA Positive Breast CancerDr. Law isAdvanced. Learn about BRCA Positive Breast Cancer.
- DICER1 SyndromeDr. Law isAdvanced. Learn about DICER1 Syndrome.
- HER-2 Positive Breast Cancer
- HER2 Negative Breast CancerDr. Law isAdvanced. Learn about HER2 Negative Breast Cancer.
- Triple-Negative Breast Cancer
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Law isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Law isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Law isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer